Functional Aptamer Selection Using Cell-Response Reporter Screening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing aptamer selection processes fail to enrich for aptamers that induce a desired cellular function, leading to inefficiencies in identifying aptamers capable of modulating target cell functions effectively.

Innovation Solution

A method involving contacting target cells with aptamer cluster particles, detecting cell-aptamer complexes undergoing a specific function, and enriching aptamers that induce desired cellular effects, such as apoptosis or immune modulation, through flow cytometry and amplification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional binding-based aptamer selection processes are used, then aptamers that bind to target cells can be identified, but aptamers that induce desired cellular functions are not enriched

Engineering Contradiction:
Improvebinding detection accuracyVSAvoidfunctional aptamer enrichment efficiency
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent introduces a reporter molecule as an intermediary that mediates between the aptamer-target cell interaction and the detection system. The reporter molecule converts the biological function (e.g., apoptosis, proliferation) into a detectable signal, enabling the selection process to specifically enrich for functionally active aptamers rather than just binders

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the detection parameter from simple binding presence to functional outcome measurement. By monitoring cellular responses (apoptosis, proliferation, activation) rather than just binding events, the selection process shifts from enriching binders to enriching functionally active aptamers

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If aptamers are selected based on binding alone, then binding aptamers are identified, but functional effects on target cells cannot be guaranteed

Engineering Contradiction:
Improveselection process simplicityVSAvoidfunctional effect reliability
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent implements a feedback mechanism where the cellular functional response is measured and used to guide the selection process. Aptamers that induce the desired functional effect are detected via the reporter signal and enriched for subsequent rounds, creating a feedback loop that continuously improves functional enrichment while maintaining process simplicity

Inventive Principle:
Principle #23Feedback

3Measurement precision

If weakly binding aptamers are used, then specific target recognition is achieved, but functional enrichment is insufficient

Engineering Contradiction:
Improvetarget recognition specificityVSAvoidfunctional aptamer yield
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent performs preliminary functional screening by incorporating the reporter system at the beginning of the selection process. This allows weakly binding aptamers with functional activity to be identified and enriched early, rather than requiring strong binders, thereby improving functional aptamer yield while maintaining target recognition specificity

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enriches aptamer libraries for aptamers that induce desired cellular functions, facilitating the identification of functional aptamers useful as therapeutics, with up to 1.5-fold functional enrichment.

Implementation Method 1

detecting the cell-aptamer cluster particle complexes undergoing the cell function

Methodology Applied
Scientific EffectLight scattering: Scattering

Implementation Method 2

detecting the cell-aptamer cluster particle complexes undergoing the cell function

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS12545906B2Methods and compositions for selection of functional aptamers
Publication Date: 2026.02.10 AUMMUNE LTD
  • US12545906B2 patent drawing
  • US12545906B2 patent drawing
  • US12545906B2 patent drawing

AI summary

The present disclosure describes compositions and methods for selection functional aptamers. In certain embodiments, provided herein are methods of using aptamer cluster-containing particles to identify functional aptamers from an aptamer library. In certain embodiments, provided herein are functionally enriched populations of aptamers. In certain embodiments, provided herein are methods for selecting an aptamer for use in personalized cancer treatment and methods for preparing a tumor delivery system. In certain embodiments, provide herein are compositions comprise the aptamer cluster-containing particles, target cells (e.g., cancer cells, immune cells, etc.) and/or a detectable indicator of cellular function (e.g., a fluorescent indicator of apoptosis, cell proliferation, gene or protein expression, etc.).